Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Sobi To Advance Gamifant® (Emapalumab) In IDS Based On Embrace Topline Data

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    07/01/2026 18:20
    Jan 7 (Reuters) - Sobi:

SOBI TO ADVANCE GAMIFANT® (EMAPALUMAB) IN INTERFERON-GAMMA-DRIVEN SEPSIS (IDS) BASED ON EMBRACE TOPLINE DATA

Source text: ID:nPreGxWcma

Further company coverage: SOBIV.ST

 ((((Reuters.Briefs@thomsonreuters.com));))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news